SCHEMBL17477235

SCHEMBL17477235

CCOC(=O)C1CNCC[C@H]1c1ccc(F)cc1

nearest known ligand 0.77

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.60
PKM P14618 1/20 0.60
SLC18A2 Q05940 3/20 0.46
HTR2A P28223 2/20 0.46
SLC6A3 Q01959 2/20 0.46
GRK2 P25098 1/20 0.43
CHEK1 O14757 2/20 0.41
CHEK2 O96017 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17485186 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL17485211 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL17486608 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL7674961 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL7674955 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL7674949 1.00 MAPT (0.60) MAPTPKMSLC18A2HTR2ASLC6A3
SCHEMBL17486605 0.90 MAPT (0.63) MAPTPKMSLC18A2SLC6A3MEN1
SCHEMBL17485268 0.90 MAPT (0.63) MAPTPKMSLC18A2SLC6A3MEN1
SCHEMBL17488515 0.89 MAPT (0.59) MAPTPKMSLC6A3CYP3A4
SCHEMBL17485168 0.87 MAPT (0.60) MAPTPKMSLC6A3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174864-A2 VMAT INHIBITORY COMPOUNDS Oregon Health & Science University (US) 2017-06-07 EP disclosed
WO-2016019312-A2 VMAT INHIBITORY COMPOUNDS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2016-02-04 WO disclosed